VITAF — Pharmaceutical Centre SA Balance Sheet
0.000.00%
Last trade - 00:00
Consumer DefensivesHighly SpeculativeMicro Cap
2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 7.83 | 6.36 | 7.07 | 8.3 | 5.64 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 24.3 | 22.6 | 27.9 | 34.2 | 36.6 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 52.1 | 51.5 | 60.9 | 67.8 | 67.5 |
Net Property, Plant And Equipment | 1.84 | 1.75 | 3.59 | 3.54 | 5.41 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 54.1 | 54.2 | 64.6 | 71.5 | 73.1 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 25.5 | 23.8 | 33.2 | 34.2 | 34.9 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 30.5 | 28.3 | 40.6 | 47 | 45.4 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 23.6 | 25.9 | 24 | 24.5 | 27.7 |
Total Liabilities & Shareholders' Equity | 54.1 | 54.2 | 64.6 | 71.5 | 73.1 |
Total Common Shares Outstanding |